 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
Kidney transplantation is a good option for people with kidney disease, but there is still
a lot to learn about how to best care for
the HIV infected kidney transplant patient.
a lot to learn about how to best care for
the HIV infected kidney transplant patient.
| Welcome to the HIVTR-CCR5 Project | |
| The primary clinical goals of this multi-center clinical trial on HIV+ kidney transplant recipients are as follows: To evaluate the impact of CCR5 blockade (maraviroc, MVC) on renal function at week 52 post-transplant; as well as evaluate the overall safety and tolerability of CCR5 blockade in the HIV+ kidney transplant recipient. The primary mechanistic goals of this trial are as follows: To define immunologic parameters associated with rejection in the HIV positive recipient (versus HIV+ non-rejectors; as well as determine the impact of CCR5 blockade on the immunologic profiles in the HIV positive recipient. |
|
 |
|